WHY WE DO IT
WHY WE DO IT
We believe that...
We believe that patients deserve better.
47% of breast cancer patients consider hair loss the most traumatic aspect of their treatment.
Research shows that hair loss has a significant impact on quality of life.
68% of all chemotherapy patients develop some form of peripheral nerve damage as a result of their treatment.
Peripheral neuropathy may have an impact on the ability to do daily activities.
These needs aren't going anywhere - and they're getting bigger.
Key opinion leaders agree that chemotherapy will remain a mainstay of cancer care, while new targeted therapies continue to cause the same old problems.
OUR VALUES
We believe in patient-driven healthcare
Patient-Oriented
We're determined to accurately understanding what people need from our technologies. Our advantage comes from putting the patient first.
Focused
We identify and prioritise the most important tasks, setting scope, and getting to the important answers quickly. We win the chance to go deeper.
Expect & Reward Excellence
We only accept excellence and require high standards of ourselves. We reward excellence by recognising it in ourselves and in our partners.
Ownership
We are all owners of our mission and our company. We have an ownership mentality - we take responsibility and empower each other.
Openness
We are open to feedback from our stakeholders and we're transparent in sharing information. We challenge ourselves to be open minded.
PEOPLE
Our Team
Aaron McCormack
R&D Manager
Dr Bárbara Oliveira
CCO & Co-Founder
Aaron Hannon
CEO & Co-Founder
Prof Martin O'Halloran
Co-Founder
Dr Ellen Cahill
VP R&D and Operations
Alma O'Reilly
Principal Quality Engineer
Roisin Ní hAmaill
Clinical Researcher
Adriana Arriaga
R&D Product Designer II
Declan Loughnane
Principal R&D Engineer
Alice Shaughnessy
R&D Engineer I
Interested in joining a world-class team that's using technology to solve the world's biggest healthcare problems?
Visit our Careers page to find out more.
BOARD
Board of Directors
Dr Bárbara Oliveira
CCO & Co-Founder
Aaron Hannon
CEO & Co-Founder
Steve Pacelli
Chairperson
BACKED BY
Investors
